DE1793465A1 - Neues Salz des Heptaminols und Verfahren zu seiner Herstellung - Google Patents

Neues Salz des Heptaminols und Verfahren zu seiner Herstellung

Info

Publication number
DE1793465A1
DE1793465A1 DE19681793465 DE1793465A DE1793465A1 DE 1793465 A1 DE1793465 A1 DE 1793465A1 DE 19681793465 DE19681793465 DE 19681793465 DE 1793465 A DE1793465 A DE 1793465A DE 1793465 A1 DE1793465 A1 DE 1793465A1
Authority
DE
Germany
Prior art keywords
heptaminol
preparation
new salt
dog
page
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19681793465
Other languages
German (de)
English (en)
Other versions
DE1793465C3 (OSRAM
Inventor
Yves Huet
Carlos Pomaret
Bernard Pourrias
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Delalande SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delalande SA filed Critical Delalande SA
Priority to DE19681793465 priority Critical patent/DE1793465A1/de
Publication of DE1793465A1 publication Critical patent/DE1793465A1/de
Application granted granted Critical
Publication of DE1793465C3 publication Critical patent/DE1793465C3/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/08—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
    • E—FIXED CONSTRUCTIONS
    • E06—DOORS, WINDOWS, SHUTTERS, OR ROLLER BLINDS IN GENERAL; LADDERS
    • E06B—FIXED OR MOVABLE CLOSURES FOR OPENINGS IN BUILDINGS, VEHICLES, FENCES OR LIKE ENCLOSURES IN GENERAL, e.g. DOORS, WINDOWS, BLINDS, GATES
    • E06B9/00—Screening or protective devices for wall or similar openings, with or without operating or securing mechanisms; Closures of similar construction
    • E06B9/02—Shutters, movable grilles, or other safety closing devices, e.g. against burglary
    • E06B9/08—Roll-type closures
    • E06B9/11—Roller shutters
    • E06B9/15—Roller shutters with closing members formed of slats or the like
    • E06B9/165—Roller shutters with closing members formed of slats or the like with slats disappearing in each other; with slats the distance between which can be altered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Structural Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Civil Engineering (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Architecture (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19681793465 1968-09-20 1968-09-20 Neues Salz des Heptaminols und Verfahren zu seiner Herstellung Granted DE1793465A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19681793465 DE1793465A1 (de) 1968-09-20 1968-09-20 Neues Salz des Heptaminols und Verfahren zu seiner Herstellung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19681793465 DE1793465A1 (de) 1968-09-20 1968-09-20 Neues Salz des Heptaminols und Verfahren zu seiner Herstellung

Publications (2)

Publication Number Publication Date
DE1793465A1 true DE1793465A1 (de) 1971-07-22
DE1793465C3 DE1793465C3 (OSRAM) 1973-01-04

Family

ID=5707715

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19681793465 Granted DE1793465A1 (de) 1968-09-20 1968-09-20 Neues Salz des Heptaminols und Verfahren zu seiner Herstellung

Country Status (1)

Country Link
DE (1) DE1793465A1 (OSRAM)

Also Published As

Publication number Publication date
DE1793465C3 (OSRAM) 1973-01-04

Similar Documents

Publication Publication Date Title
DE69003229T2 (de) Entzündungshemmendes Mittel in einer Zusammensetzung.
DE69106656T2 (de) Tanninextrakt von Kastanienholz, Verfahren zu deren Herstellung und deren Verwendung.
DE3929582A1 (de) Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
DE2552869A1 (de) Pharmazeutische zusammensetzungen mit piperidylindol-derivaten und deren herstellung
DE2403122C2 (OSRAM)
DE2716402A1 (de) 7-(2,3-dihydroxypropyl)-1,3-di-n- propylxanthin, verfahren zu seiner herstellung und diese verbindung enthaltende arzneimittel
DE1940566C3 (de) 1- (2-Nitrilophenoxy)-2-hydroxy-3äthylaminopropan, Verfahren zu dessen Herstellung und dieses enthaltende Arzneimittel
CH638681A5 (en) Pharmaceutical containing Echinacea and lactic acid derivatives and process for its preparation
DE2333831C3 (de) l-(2-Benzoyl-äthyl)-2-(4-a- cinnamylpiperazinomethyQ-benzimidazole, Verfahren zur ihrer Herstellung und ihre therapeutische Verwendung
DE1967324C2 (de) 3-(3,4,5-Trimethoxybenzamido)-piperidin, Verfahren zu dessen Herstellung und die Verbindung enthaltende Arzneimittel
DE1793465C3 (OSRAM)
DE3205149C2 (OSRAM)
DE2038628B2 (de) N,N'-Di(carboxyalkyl)-p-phenylendiamine, deren Salze und Diäthylester, Verfahren zu ihrer Herstellung und ihre Verwendung
DE2521905C2 (de) Arzneimittel zur cerebralen Durchblutungsförderung
DE1936723A1 (de) Alkaloidsalze der Chinarinde und Verfahren zu ihrer Herstellung
DE1695284B2 (de) Substituierte-2-amino-4,5-diphenyl- oxazolderivate
AT319934B (de) Vzh der neuen 5-n-pyrrylsalicylsaeure und ihrer salze
DE1767666B2 (de) Pharmazeutische Zubereitung gegen , Lebererkrankungen
AT330953B (de) Verfahren zur herstellung eines pharmazeutischen praparates zur verbesserung der zellatmung
DE1767352C (de) Subkutan zu verabreichendes Veterinär-Arzneimittel zur Verbesserung des Fleischansatzes
DE2228289C2 (de) 1-(6-Hydroxyhexyl)-2(1H)-pyridinon
DE1793465B (de) Salz der Zimtsaure mit 6 Ammo 2 methyl 2 heptanol
DE1933179C3 (de) 2-Benzimfdazolylmethyl-piperazinderivate, deren Maleate, Verfahren zu Ihrer Herstellung und Arzneimittel
DE1695907C3 (de) Verwendung von 3,5-Dimethyl-l,2oxazinon-(6)
AT330748B (de) Verfahren zur herstellung von neuen 1- phenoxy-2-hydroxy-3-propargylaminopropanen und von deren saureadditionssalzen

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee